Ninepoint Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$583K Hold
2,815
0.06% 99
2025
Q3
$522K Buy
+2,815
New +$482K 0.07% 92
2023
Q1
Sell
-2,656
Closed -$469K 90
2022
Q4
$469K Hold
2,656
0.06% 47
2022
Q3
$434K Buy
+2,656
New +$449K 0.05% 46
2022
Q2
Sell
-2,662
Closed -$472K 89
2022
Q1
$472K Buy
+2,662
New +$453K 0.1% 56
2021
Q4
Sell
-2,862
Closed -$462K 85
2021
Q3
$462K Hold
2,862
0.12% 52
2021
Q2
$471K Buy
2,862
+99
+4% +$16.4K 0.11% 55
2021
Q1
$454K Buy
+2,763
New +$447K 0.18% 51
2020
Q4
Sell
-2,636
Closed -$392K 88
2020
Q3
$392K Buy
2,636
+276
+12% +$40.8K 0.17% 39
2020
Q2
$332K Buy
+2,360
New +$344K 0.13% 46

Other funds holding JNJ

Ninepoint Partners's JNJ Position: Q4 2025 in Review

Ninepoint Partners held its Johnson & Johnson (JNJ) position steady in Q4 2025 at 2,815 shares worth $583K. The position accounts for 0.06% of the portfolio, ranked #99.

Ninepoint Partners first reported a position in JNJ in Q2 2020 and has held it in 10 quarters since. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Ninepoint Partners held 2,815 shares of Johnson & Johnson worth $583K as of Q4 2025.
  • Ninepoint Partners left its Johnson & Johnson share count unchanged in Q4 2025.
  • Johnson & Johnson made up 0.06% of Ninepoint Partners's portfolio in Q4 2025, its #99 holding.
  • Ninepoint Partners first reported a position in Johnson & Johnson in Q2 2020 and has held it in 10 quarters since.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Ninepoint Partners's 13F filing for Q4 2025, filed 17 Feb 2026.